Betnovate Scalp Application Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Betamethasone valerate

Indications/Uses

Treatment of steroid-responsive scalp dermatoses (eg, psoriasis, seborrhea capitis, inflammation associated w/ severe dandruff).

Click to view Betnovate Scalp Application detailed prescribing information

Dosage/Direction for Use

Apply to the scalp at night & morning. May apply once daily to sustain improvement.

Click to view Betnovate Scalp Application detailed prescribing information

Overdosage

View Betnovate Scalp Application overdosage for action to be taken in the event of an overdose.

Contraindications

Scalp infection; dermatoses including dermatitis in childn <1 yr.

Click to view Betnovate Scalp Application detailed prescribing information

Special Precautions

Hypersensitivity. W/draw if manifestations of Cushing's syndrome & reversible hypothalamic-pituitary-adrenal axis suppression occur. Increased risk of systemic effects. Psoriasis. Avoid smoking or being near an open flame during application & immediately after use. Pregnancy & lactation. Infants & childn <12 yr.

Click to view Betnovate Scalp Application detailed prescribing information

Use In Pregnancy & Lactation

Click to view Betnovate Scalp Application detailed prescribing information

Adverse Reactions

Pruritus, local skin burning/skin pain.

Click to view Betnovate Scalp Application detailed prescribing information

Drug Interactions

Increased systemic exposure w/ CYP3A4 inhibitors eg, ritonavir, itraconazole.

Click to view Betnovate Scalp Application detailed prescribing information

Storage

View Betnovate Scalp Application storage conditions for details to ensure optimal shelf-life.

Action

View Betnovate Scalp Application mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Topical Corticosteroids

ATC Classification

D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Betnovate Scalp Application scalp application 1 mg/mL

Packing/Price

30 mL x 1's (P539.5/container)

Betnovate Scalp Application

betamethasone

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig